36 related articles for article (PubMed ID: 25035203)
1. Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
Beck AC; Bayard S; Plitas G; Sevilimedu V; Kuba MG; Garcia P; Morrow M; Tadros AB
Ann Surg Oncol; 2023 Oct; 30(10):6061-6069. PubMed ID: 37493892
[TBL] [Abstract][Full Text] [Related]
2. Residual Risk of Ipsilateral Tumor Recurrence in Patients Who Achieved Clear Lumpectomy Margins After Repeated Resection.
Cheun JH; Kim HK; Lee HB; Han W; Moon HG
J Breast Cancer; 2023 Dec; 26(6):558-571. PubMed ID: 37985383
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC).
Ricceri F; Fasanelli F; Giraudo MT; Sieri S; Tumino R; Mattiello A; Vagliano L; Masala G; Quirós JR; Travier N; Sánchez MJ; Larranaga N; Chirlaque MD; Ardanaz E; Tjonneland A; Olsen A; Overvad K; Chang-Claude J; Kaaks R; Boeing H; Clavel-Chapelon F; Kvaskoff M; Dossus L; Trichopoulou A; Benetou V; Adarakis G; Bueno-de-Mesquita HB; Peeters PH; Sund M; Andersson A; Borgquist S; Butt S; Weiderpass E; Skeie G; Khaw KT; Travis RC; Rinaldi S; Romieu I; Gunter M; Kadi M; Riboli E; Vineis P; Sacerdote C
Int J Cancer; 2015 Aug; 137(4):940-8. PubMed ID: 25650288
[TBL] [Abstract][Full Text] [Related]
4. Locoregional outcomes in clinical stage IIB breast cancer after neoadjuvant therapy and mastectomy with or without radiation.
Diaz DA; Hurley J; Reis I; Takita C; Zhao W; Wright J
Medicine (Baltimore); 2014 Dec; 93(29):e230. PubMed ID: 25546661
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
[TBL] [Abstract][Full Text] [Related]
6. Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801.
Black DM; Hunt KK; Mittendorf EA
Gland Surg; 2013 Aug; 2(3):120-3. PubMed ID: 25083471
[TBL] [Abstract][Full Text] [Related]
7. Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
Bundred JR; Michael S; Stuart B; Cutress RI; Beckmann K; Holleczek B; Dahlstrom JE; Gath J; Dodwell D; Bundred NJ
BMJ; 2022 Sep; 378():e070346. PubMed ID: 36130770
[TBL] [Abstract][Full Text] [Related]
8. Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
Nakhlis F; Katlin FD; Grossmith SC; DiPasquale A; Harrison BT; Schnitt SJ; King TA
Ann Surg Oncol; 2022 Nov; 29(12):7696-7702. PubMed ID: 35771367
[TBL] [Abstract][Full Text] [Related]
9. Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer.
Chatzikonstantinou G; Strouthos I; Scherf C; Köhn J; Solbach C; Rödel C; Tselis N
J Radiat Res; 2021 May; 62(3):465-472. PubMed ID: 33604659
[TBL] [Abstract][Full Text] [Related]
10. Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy.
Kitagawa M; Someya M; Hasegawa T; Mikami T; Asaishi K; Hasegawa T; Matsumoto Y; Kutomi G; Takemasa I; Sakata KI
Strahlenther Onkol; 2019 Jul; 195(7):648-658. PubMed ID: 30997540
[TBL] [Abstract][Full Text] [Related]
11. Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Geurts-Giele WR; van Verschuer VM; van Deurzen CH; van Diest PJ; Pedrosa RM; Collée JM; Koppert LB; Seynaeve C; Dinjens WN
Mod Pathol; 2017 Jan; 30(1):15-25. PubMed ID: 27612322
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
13. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
[TBL] [Abstract][Full Text] [Related]
15. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
16. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
Moran MS; Schnitt SJ; Giuliano AE; Harris JR; Khan SA; Horton J; Klimberg S; Chavez-MacGregor M; Freedman G; Houssami N; Johnson PL; Morrow M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):553-64. PubMed ID: 24521674
[TBL] [Abstract][Full Text] [Related]
17. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.
Spronk I; Schellevis FG; Burgers JS; de Bock GH; Korevaar JC
Breast; 2018 Jun; 39():70-79. PubMed ID: 29621695
[TBL] [Abstract][Full Text] [Related]
18. Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.
Jobsen J; van der Palen J; Riemersma S; Heijmans H; Ong F; Struikmans H
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1006-1014. PubMed ID: 25035203
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
